Skip to main content
LobbyMap

Atlantic Pharma Holdings

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
48/100
Moderate Influence
$3.2M
Total Lobby Spend
6
Policy Issues
1
Lobbyists
0
Revolving Door

Atlantic Pharma Holdings reported $3.2 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

US Trade Representative
Dept of Interior
Dept of State
White House
Dept of Agriculture
Dept of Housing & Urban Development
Centers for Medicare & Medicaid Services

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarBGR Group LLP
HCRPOS
1$206K
2020 Apr-JunHolland & Knight LLP
AERPHA
1$202K
2020 Jul-SepCovington & Burling LLP
POSMEDHCR+2
1$138K
2020 Oct-DecK&L Gates LLP
AERPHA
1$238K
2021 Jan-MarK&L Gates LLP
MED
1$82K
2021 Apr-JunBrownstein Hyatt LLP
GOVPHAPOS+1
1$82K
2021 Jul-SepHolland & Knight LLP
PHA
1$121K
2021 Oct-DecK&L Gates LLP
HCRMEDPOS
1$87K

Atlantic Pharma Holdings Lobbying FAQ

Atlantic Pharma Holdings has spent $3.2M on federal lobbying across 6 policy areas. This includes spending on registered lobbyists and direct government contacts.

Atlantic Pharma Holdings lobbies on 6 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Atlantic Pharma Holdings has an Influence Score of 48/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Atlantic Pharma Holdings employs 1 registered lobbyists, of whom 0 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Atlantic Pharma Holdings has contacted 7 government entities as part of their lobbying activities, including US Trade Representative, Dept of Interior, Dept of State.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.